Back to today’s briefing

Story perspectives

Kennedy Proposes TV Ad Reforms That Could Impact Drug Companies

6/18/2025

42 9

Left

Kennedy Considers Pharma Reform

US Health and Human Services Secretary Robert F. Kennedy Jr. is contemplating transformative policies that could reshape pharmaceutical advertising on TV. If implemented, these changes may force drug companies to provide clearer risk disclosures or lose tax benefits, jeopardizing a crucial $5.15 billion revenue stream for broadcasters in 2024.

Center

Sarepta Halts Shipments

Sarepta Therapeutics has halted shipments of its Duchenne muscular dystrophy gene therapy following two tragic patient deaths from acute liver failure. In a related move, Senators Bernie Sanders and Angus King are advocating for a bill to ban direct-to-consumer pharmaceutical advertising, echoing Health Secretary Robert F. Kennedy Jr.'s concerns about public health risks.

1 of 2

Kennedy Considers Pharma Reform

US Health and Human Services Secretary Robert F. Kennedy Jr. is contemplating transformative policies that could reshape pharmaceutical advertising on TV. If implemented, these changes may force drug companies to provide clearer risk disclosures or lose tax benefits, jeopardizing a crucial $5.15 billion revenue stream for broadcasters in 2024.

1 / 2